Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone to treat multiple myeloma (MM) patients progressing or relapsing after autologous transplantation: the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia

Details

Request a copyRequest a copy
Serval ID
serval:BIB_5735726CA210
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Abstract (Abstract): shot summary in a article that contain essentials elements presented during a scientific conference, lecture or from a poster.
Collection
Publications
Institution
UNIL/CHUV
Title
Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone to treat multiple myeloma (MM) patients progressing or relapsing after autologous transplantation: the MMVAR trial, a study from the myeloma subcommittee of the Chronic Leukemia
Title of the conference
36th Annual Meeting of the European Group for Blood and Marrow Transplantation
Author(s)
Garderet L., Iacobelli S., Moreau P., Onida F., Koenecke C., Scheid C., Doyen C., Bouko Y., Ketterer N., Masszi T., Crawley C., Hajek R., Linkesch W., Ludwig H., Harousseau J.L., Michalet M., De Witte T., Niederwieser D., Gahrton G., Morris C.
Address
Vienna, Austria, March, 21-24, 2010
Publication state
Published
Issued date
2010
Language
english
OAI-PMH
oai:serval.unil.ch:BIB_5735726CA210
Create date
26/08/2010 13:41
Last modification date
20/08/2019 15:11
Usage data